O A, Chinese Hero Study G. The demographics, treatment characteristics and excellent of life of adult peopleHuang et al. BMC Overall health Solutions Research(2022) 22:Page 9 of11. 12. 13. 14. 15.16. 17. 18.19. 20. 21. 22. 23. 24. 25. 26. 27. 28.29.30. 31. 32. 33.with haemophilia in China – final results in the HERO study. Haemophilia. 2017;23(1):897. Dong ZH, Chen BB, Li ZQ. Health-related insurance coverage and management analysis of hemophilia according to the knowledge of Shenzhen. China Health Insurance. 2018;1:32. Song XW, Liu W, Xue F, Zhong J, Yang YF, Liu Y, et al. Real-world evaluation of haemophilia patients in China: A single centre’s encounter. Haemophilia. 2020;26(4):5840. Gong GW, Chen YC, Fang PQ, Min R. Medical expenditure for patients with hemophilia in urban China: information from medical insurance coverage data system from 2013 to 2015. Orphanet J Uncommon Dis. 2020;15(1):137. Meng Q, Fang H, Liu X, Yuan B, Xu J. Consolidating the social health insurance coverage schemes in China: towards an equitable and effective wellness technique. Lancet. 2015;386(10002):14842. Yang Y, Man X, Nicholas S, Li S, Bai Q, Huang L, et al. Utilisation of well being solutions amongst urban individuals who had an ischaemic stroke with unique wellness insurance coverage – a cross-sectional study in China. BMJ Open. 2020;ten(10):e040437. Zhu D, Ding R, Ma Y, Chen Z, Shi X, He P. Comorbidity in lung cancer sufferers and its association with hospital readmission and fatality in China. BMC Cancer. 2021;21(1):557. Tencer T, Friedman HS, Li-McLeod J, Johnson K. Medical fees and resource utilization for hemophilia patients with and without the need of HIV or HCV infection. J Manag Care Pharm. 2007;13(9):79098. Zhang H, Sun Y, Zhang D, Zhang C, Chen G. Direct medical costs for sufferers with schizophrenia: a 4-year cohort study from health insurance claims information in Guangzhou city, Southern China. Int J Ment Well being Syst. 2018;12:72. Zhu D, Shi X, Nicholas S, Chen S, Ding R, Huang L, et al. Healthcare Service Hospital utilization and Direct Healthcare Expense of Stroke in Urban China. Int J Well being Policy Manag. 2020;11(three):2776. Consensus of Chinese professional on the diagnosis and therapy of hemophilia (version 2017). Chin J Hematol,2017,38(05):36470. Srivastava A, Brewer AK, Mauser-Bunschoten EP, Important NS, Kitchen S, Llinas A, et al. Recommendations for the management of hemophilia. Haemophilia. 2013;19(1):E1-E47. Srivastava A, Santagostino E, Dougall A, Kitchen S, Sutherland M, Pipe SW, et al. WFH Suggestions for the Management of Hemophilia, 3rd Edition. Haemophilia. 2020;26(S6):158. Shrestha A, Eldar-Lissai A, Hou N, Lakdawalla DN, Batt K. Real-world resource use and charges of haemophilia A-related bleeding. Haemophilia. 2017;23(four):e267-e75. Gharibnaseri Z, Davari M, Cheraghali A, Eshghi P, Ravanbod R, Espandar R, et al.CTHRC1 Protein manufacturer Health care resource hospital utilization and price of care for haemophilia A and B patients in Iran.IL-6, Mouse Transfus Apher Sci.PMID:26780211 2016;54(1):122. Zhou ZY, Koerper MA, Johnson KA, Riske B, Baker JR, Ullman M, et al. Burden of illness: direct and indirect fees among persons with hemophilia A inside the United states of america. J Med Econ. 2015;18(6):4575. Rocha P, Carvalho M, Lopes M, Ara o F. Charges and hospital utilization of therapy in patients with hemophilia. BMC Well being Serv Res. 2015;15:484. Polack B, Calvez T, Chambost H, Rothschild C, Goudemand J, Claeyssens S, et al. EQOFIX: a combined economic and quality-of-life study of hemophilia B remedies in France. Transfusion. 2015;55(7):17877. Globe DR, Curtis RG, Koerper MA, Comm HS. Hospital utilization of ca.